Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cambio Provides Microzone PCR and DNA Reagents to Life Science Market

Published: Thursday, April 25, 2013
Last Updated: Thursday, April 25, 2013
Bookmark and Share
Cambio supplies Microzone’s MegaMix, microLYSIS® and MicroCLEAN products.

Cambio is able to supply its customers with a selection of reagents by Microzone. MegaMix, microLYSIS® and MicroCLEAN are each specifically designed as convenient and efficient solutions for PCR, DNA release and DNA clean-up respectively.

By incorporating these reagents into their procedures, life scientists can save time that would otherwise be spent creating their own mixes, as well as reducing risk of contamination.

Thanks to their standardized formulation, the Microzone reagents also dramatically increase the reproducibility of DNA amplification, giving researchers the upmost confidence in their methods, and therefore their results.

MegaMix is a PCR master mix containing all the fixed components needed for PCR amplification, including an enzyme cocktail consisting of two Taq polymerases, dNTPs, MgCl2, reaction buffers and enzyme stabilizers.

All these components are optimized to maximize yield with minimal non-specific background and the product is exceptionally easy to use - the MegaMix just has to be thawed, the recommended volume drawn and DNA and primers added.

MegaMix can survive multiple freeze/thaw cycles without deterioration of either product or function.

MegaMix is also available with dye to allow easy visualization, and double concentrated for added convenience.

In addition, Cambio also supplies Microzone’s MicroCLEAN and microLYSIS® products. MicroCLEAN is a rapid, one tube, one and half spin DNA reagent which cleans up any double stranded DNA from reaction buffers, enzymes, primers or dNTPs.

The versatile reagent has no limit on the size or volume of the target DNA and requires no additional manipulation, such as phenol extractions or spin columns.

Finally, microLYSIS® and microLYSIS®-Plus are novel reagents designed for use as a pre-step to PCR. When combined with rapid heating and cooling of thermocyclers, the unique mycroLYSIS® formulation effectively lyses the cells and enables users to reach the PCR stage in less than 15 minutes.

For tougher cell samples, such as those found in plant and some animal tissues, microLYSIS®-Plus can still offer the same impressive results.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!